English (UK)
中文版Tracy HOU
Tonghua Dongbao Pharmaceutical Co.,LTD is a healthy medicine enterprise which devotes to R&D, manufacturing and sales of high quality pharmaceutics. The company was established in 1985, listed in Shanghai Stocks Exchange in 1994 (600867).By the end of 2019, we have 2,700 employees including 300 R& D persons. Tonghua Dongbao has became a well known industrial manufacturer of recombinant human insulin, and has constructed National enterprise technical center and Post-doctoral Scientific research station.
Tonghua Dongbao Pharma Co., Ltd
Senior BD ManagerDaniel Hu
Laurel Venture Capital is a life science focused venture capital firm with expertise on investment in innovative and breakthrough early stage therapeutics and technologies worldwide.
朗煜资本
BD DIRECTORMr Kaijun Huang
Private Equity investment platform of ICBC.
ICBC Asia investment is a wholly-owned holding equity investment platform of industrial and commercial bank of China (ICBC). Managing over 44 billion yuan unlist equity investment. Direct investment over 172 projects, indirect investment in over 2400 companies.
ICBC Asia Investment
Investment Director
Lisi Huang
Foncoo is a Chiba-based specialty pharma company. We are looking for opportunities in CNS area.
Responsive Web Design powered by 